# Effect of Obesity on Aquaporin5 Expression in Human Placental and Uterus Tissues

## TL;DR

This study explores how obesity affects AQP5 levels in placental and uterine tissues, suggesting a link to pregnancy duration and potential drug targets.

## Contribution

The study provides new insights into AQP5 expression changes in obese pregnant women and their potential role in pregnancy outcomes.

## Key findings

- AQP5 expression increased in the uterus but not in the placenta of obese mothers.
- Placental volume increased and vascularization decreased in obese mothers.
- TAC levels in plasma decreased among overweight mothers.

## Abstract

Background: Obesity and overweight are also becoming more prevalent among women of childbearing age and pregnant women. In maternal obesity, the activation of metabolic, inflammatory, and oxidative stress pathways is proven, which appears to be a key step in the pathological changes observed in placental and uterine function. Several recent studies have evidenced that aquaporins (AQPs) are critical players in adipose tissue biology and are involved in the onset of obesity. Methods: Our studies aimed to investigate the changes in placental volume and vascularization and measure the AQP5 expression and total antioxidant capacity (TAC) in the placenta and uterus tissues in obese and typical-weight mothers. We also aim to measure the AQP5 plasma concentration. Results: We found AQP5 dominance in the uterus and plasma at 34 weeks of normal pregnancy. The placental volume increased and the vascularization decreased in obese mothers compared to the control. The AQP5 expression increased in the uterus of the obese group and did not change in the placenta. The TAC decreased in the plasma of overweight mothers. Conclusions: We hypothesize that increased AQP5 expression prolongs the length of pregnancy and inhibits the onset of contractions. Based on our findings, we can develop diagnostic tests and provide new targets for tocolytic drug development.